Clinical Trial

Phenotypic Manifestations of Hereditary ATTR Amyloidosis

Name: Phenotypic Manifestations of Hereditary ATTR Amyloidosis — clinical trial record (NCT07124377)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

This study focuses on hereditary transthyretin amyloidosis (ATTRv) with the Val50Met variant in a non endemic aerea

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-08-08.

Status change: Enrolling by Invitation → Recruiting 2026-03-27

Trial Details

NCT Number	NCT07124377
Lead Sponsor	Hospital 9 de Julio de Las Breñas Collaborators: Instituto de Cardiología de Corrientes
Conditions	Hereditary Amyloidosis, Transthyretin-Related
Enrollment	57 participants
Start Date	2024-09-01
Primary Completion	2026-12-30 (estimated)
Study Completion	2027-03-01 (estimated)
Updated on ClinicalTrials.gov	2026-04-02